The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults
Open accessAbstract
BACKGROUND: This is an updated version of the original Cochrane review published in Issue 1, 2010, on 'Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults'. Breathlessness is one of the most common symptoms experienced in the advanced stages of malignant and non-malignant disease. Benzodiazepines are widely used for the relief of breathlessness in advanced diseases and are regularly recommended in the literature. At the time of the previously published Cochrane review, there was no evidence for a beneficial effect of benzodiazepines for the relief of breathlessness in people with advanced cancer and chronic obstructive pulmonary disease (COPD). OBJECTIVES: The primary objective of this review was to determine the efficacy of benzodiazepines for the relief of breathlessness in people with advanced disease. Secondary objectives were to determine the efficacy of different benzodiazepines, different doses of benzodiazepines, different routes of application, adverse effects of benzodiazepines, and the efficacy in different disease groups. SEARCH METHODS: This is an update of a review published in 2010. We searched 14 electronic databases up to September 2009 for the original review. We checked the reference lists of all relevant studies, key textbooks, reviews, and websites. For the update, we searched CENTRAL, MEDLINE, and EMBASE and registers of clinical trials for further ongoing or unpublished studies, up to August 2016. We contacted study investigators and experts in the field of palliative care asking for further studies, unpublished data, or study details when necessary. SELECTION CRITERIA: We included randomised controlled trials (RCTs) and controlled clinical trials (CCTs) assessing the effect of benzodiazepines compared with placebo or active control in relieving breathlessness in people with advanced stages of cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), motor neurone disease (MND), and idiopathic pulmonary fibrosis (IPF). DATA COLLECTION AND ANALYSIS: Two review authors independently assessed identified titles and abstracts. Three review authors independently performed assessment of all potentially relevant studies (full text), data extraction, and assessment of methodological quality. We carried out meta-analysis where appropriate. MAIN RESULTS: Overall, we identified eight studies for inclusion: seven in the previous review and an additional study for this update. We also identified two studies awaiting classification in this update. The studies were small (a maximum number of 101 participants) and comprised data from a total of 214 participants with advanced cancer or COPD, which we analysed. There was only one study of low risk of bias. Most of the studies had an unclear risk of bias due to lack of information on random sequence generation, concealment, and attrition. Analysis of all studies did not show a beneficial effect of benzodiazepines for the relief of breathlessness (the primary outcome) in people with advanced cancer and COPD (8 studies, 214 participants) compared to placebo, midazolam, morphine, or promethazine. Furthermore, we observed no statistically significant effect in the prevention of episodic breathlessness (breakthrough dyspnoea) in people with cancer (after 48 hours: risk ratio of 0.76 (95% CI 0.53 to 1.09; 2 studies, 108 participants)) compared to morphine. Sensitivity analyses demonstrated no statistically significant differences regarding type of benzodiazepine, dose, route and frequency of delivery, duration of treatment, or type of control. Benzodiazepines caused statistically significantly more adverse events, particularly drowsiness and somnolence, when compared to placebo (risk difference 0.74 (95% CI 0.37, 1.11); 3 studies, 38 participants). In contrast, two studies reported that morphine caused more adverse events than midazolam (RD -0.18 (95% CI -0.31, -0.04); 194 participants). AUTHORS' CONCLUSIONS: Since the last version of this review, we have identified one new study for inclusion, but the conclusions remain unchanged. There is no evidence for or against benzodiazepines for the relief of breathlessness in people with advanced cancer and COPD. Benzodiazepines caused more drowsiness as an adverse effect compared to placebo, but less compared to morphine. Benzodiazepines may be considered as a second- or third-line treatment, when opioids and non-pharmacological measures have failed to control breathlessness. There is a need for well-conducted and adequately powered studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Bausewein, C., Booth, S., Gysels, M., & Higginson, I. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005623.pub2 · Cited by 211
Self-citationRetractedOpioids for the palliation of breathlessness in advanced disease and terminal illness.
Jennings, A. L., Davies, A. N., Higgins, J. P., Anzures-Cabrera, J., & Broadley, K. E. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002066 · Cited by 189
RetractedOxygen therapy for dyspnoea in adults
Cranston, J. M., Crockett, A. J., & Currow, D. C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004769.pub2 · Cited by 116
RetractedCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2042st · Cited by 1,844
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update
Fabbri, L. M., & Hurd, S. S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00063703 · Cited by 1,277
Solano, J. P., Gomes, B., & Higginson, I. J. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.06.007 · Cited by 1,191
Self-citationPublished by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Dyspnea Mechanisms, Assessment and Management: A Consensus Statement
Editorial, A. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-2-9-36 · Cited by 808
Lanken, P. N., Terry, P. B., DeLisser, H. M., Fahy, B. F., Hansen-Flaschen, J., Heffner, J. E., Levy, M., Mularski, R. A., Osborne, M. L., Prendergast, T. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-587st · Cited by 713
Oxford Textbook of Palliative Medicine
Wee, B. (2004) · Journal of the Royal Society of Medicine · doi:10.1177/014107680409700720 · Cited by 710
Adrian Edwards, G. E. (2001) · Journal of Health Communication · doi:10.1080/10810730150501413 · Cited by 491
Manning, H. L., & Schwartzstein, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332307 · Cited by 472
Seow, H., Barbera, L., Sutradhar, R., Howell, D., Dudgeon, D., Atzema, C., Liu, Y., Husain, A., Sussman, J., & Earle, C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7173 · Cited by 462
Moens, K., Higginson, I. J., Harding, R., Brearley, S., Caraceni, A., Cohen, J., Costantini, M., Deliens, L., Francke, A. L., Kaasa, S., et al. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.11.009 · Cited by 445
Self-citationMidazolam: A review of therapeutic uses and toxicity
Nordt, S. P., & Clark, R. F. (1997) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(97)00022-x · Cited by 337
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
Ekstrom, M. P., Bornefalk-Hermansson, A., Abernethy, A. P., & Currow, D. C. (2014) · BMJ · doi:10.1136/bmj.g445 · Cited by 296
Bausewein, C., Booth, S., Gysels, M., & Higginson, I. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005623.pub3 · Cited by 284
Self-citationBorson, S., McDonald, G. J., Gayle, T., Deffebach, M., Lakshminarayan, S., & VanTuinen, C. (1992) · Psychosomatics · doi:10.1016/s0033-3182(92)71995-1 · Cited by 277
Health centres of today; Finsbury, Peckham.
STEWART, A. B., & Williamson, G. S. (1946) · PubMed · Cited by 256
Symptoms Experienced in the Last Six Months of Life in Patients with End-Stage Heart Failure
Nordgren, L., & Sörensen, S. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00059-8 · Cited by 243
Woodcock, A. A., Gross, E. R., Gellert, A., Shah, S., Johnson, M., & Geddes, D. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052703 · Cited by 242
Currow, D. C., Smith, J., Davidson, P. M., Newton, P. J., Agar, M. R., & Abernethy, A. P. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.09.017 · Cited by 240
OXYGEN RELIEVES BREATHLESSNESS IN "PINK PUFFERS"
Woodcock, A. A., Gross, E. R., & Geddes, D. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91612-3 · Cited by 233
Navigante, A. H., Cerchietti, L. C. A., Castro, M. A., Lutteral, M. A., & Cabalar, M. E. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.06.009 · Cited by 222
Dolly, F. R., & Block, A. J. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90185-1 · Cited by 213
Cherny, N. I. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu238 · Cited by 210
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers.
Woodcock, A. A., Gross, E. R., & Geddes, D. M. (1981) · BMJ · doi:10.1136/bmj.283.6287.343 · Cited by 173
Muers, M. F., & Round, C. E. (1993) · Thorax · doi:10.1136/thx.48.4.339 · Cited by 171
The Effectiveness of One-to-one Risk-communication Interventions in Health Care: A Systematic Review
Edwards, A., Hood, K., Matthews, E., Russell, D., Russell, I., Barker, J., Bloor, M., Burnard, P., Covey, J., Pill, R., et al. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000305 · Cited by 168
Mental Health and World Citizenship
(1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382309 · Cited by 164
Dyspnea in relation to symptoms of anxiety and depression: A prospective population study
Neuman, Å., Gunnbjörnsdóttir, M., Tunsäter, A., Nyström, L., Franklin, K. A., Norrman, E., & Janson, C. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.01.016 · Cited by 156
Personalised risk communication for informed decision making about taking screening tests
Edwards, A., Evans, R. M., Hood, K., & Elwyn, G. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001865.pub2 · Cited by 142
Textbook of Palliative Medicine
(2009) · CRC Press eBooks · doi:10.1201/b13272 · Cited by 133
Management of dyspnea in advanced cancer patients
Ripamonti, C. I. (1999) · Supportive Care in Cancer · doi:10.1007/s005200050255 · Cited by 133
The management of dyspnea in cancer patients: a systematic review
Viola, R., Kiteley, C., Lloyd, N. S., Mackay, J. A., Wilson, J., Wong, R. K. S., & Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0389-6 · Cited by 117
Breathlessness in Patients with Chronic Airflow Limitation
O’Donnell, D. E. (1994) · CHEST Journal · doi:10.1378/chest.106.3.904 · Cited by 115
Booth, S., Moosavi, S. H., & Higginson, I. J. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1034 · Cited by 113
Self-citationStark, R., Gambles, S. A., & Lewis, J. (1981) · Clinical Science · doi:10.1042/cs0610429 · Cited by 113
Effect of Alprazolam on Exercise and Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
Man, G. C., Hsu, K. Y., & Sproule, B. J. (1986) · CHEST Journal · doi:10.1378/chest.90.6.832 · Cited by 111
Argyropoulou, P., Patakas, D., Koukou, A., Vasiliadis, P., & Georgopoulos, D. (2009) · Respiration · doi:10.1159/000196202 · Cited by 106
Steens, R. D., Pouliot, Z., Millar, T. W., Kryger, M. H., & George, C. F. (1993) · SLEEP · doi:10.1093/sleep/16.4.318 · Cited by 103
Dorman, S., Jolley, C. J., Abernethy, A. P., Currow, D. C., Johnson, M. J., Farquhar, M. C., Griffiths, G. O., Peel, T., Moosavi, S. H., Byrne, A., et al. (2009) · Palliative Medicine · doi:10.1177/0269216309102520 · Cited by 103
Self-citationDiazepam in the Treatment of Dyspnoea in the ‘Pink Puffer’ Syndrome
Mitchell-Heggs, P., Murphy, K., Minty, K., Guz, A., Patterson, S., Minty, P. S. B., & Rosser, R. (1980) · QJM · doi:10.1093/oxfordjournals.qjmed.a067609 · Cited by 99
Advanced Chronic Obstructive Pulmonary Disease: Innovative Approaches to Palliation
Rocker, G. M., Sinuff, T., Horton, R., & Hernandez, P. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2007.9951 · Cited by 95
Clinical management of dyspnoea
Thomas, J. R., & von Gunten, C. F. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00713-1 · Cited by 94
Assessment and Management of Breathlessness
Altose, M. D. (1985) · CHEST Journal · doi:10.1378/chest.88.2.77s · Cited by 93
Breathlessness in Patients with Severe Chronic Airflow Limitation
O’Donnell, D. E., & Webb, K. A. (1992) · CHEST Journal · doi:10.1378/chest.102.3.824 · Cited by 92
Tobin, M. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.8.1604 · Cited by 91
Simon, S. T., Weingärtner, V., Higginson, I. J., Voltz, R., & Bausewein, C. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.06.013 · Cited by 88
Self-citationNavigante, A., Castro, M., & Cerchietti, L. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.10.003 · Cited by 87
Breathlessness in Patients With Severe Chronic Airflow Limitation
O'Donnell, D. E., & Webb, K. A. (1993) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199301000-00015 · Cited by 87
Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study
Höijer, U., Hedner, J. A., Ejnell, H., Grunstein, R. R., Odelberg, E., & Elam, M. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112011 · Cited by 83
Rose, C., Wallace, L., Dickson, R., Ayres, J., Lehman, R., Searle, Y., & Sherwood Burge, P. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(02)00004-6 · Cited by 82
The management of chronic breathlessness in patients with advanced and terminal illness
Ekström, M. P., Abernethy, A. P., & Currow, D. C. (2015) · BMJ · doi:10.1136/bmj.g7617 · Cited by 81
Rice, K. L., Kronenberg, R. S., Hedemark, L. L., & Niewoehner, D. E. (1987) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(87)90163-x · Cited by 78
ABC of palliative care: Breathlessness, cough, and other respiratory problems
Davis, C. L. (1997) · BMJ · doi:10.1136/bmj.315.7113.931 · Cited by 76
Episodic and Continuous Breathlessness: A New Categorization of Breathlessness
Simon, S. T., Higginson, I. J., Benalia, H., Gysels, M., Murtagh, F. E., Spicer, J. F., & Bausewein, C. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.06.008 · Cited by 73
Self-citationSingh, N. P., Despars, J. A., Stansbury, D. W., Avalos, K., & Light, R. W. (1993) · CHEST Journal · doi:10.1378/chest.103.3.800 · Cited by 69
Personalised risk communication for informed decision making about entering screening programs
Edwards, A., Unigwe, S., Elwyn, G. J., & Hood, K. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001865 · Cited by 68
Forster, A., Morel, D. R., Bachmann, M., & GEMPERLE, M. (1983) · Anesthesia & Analgesia · doi:10.1213/00000539-198310000-00012 · Cited by 68
Murciano, D., Armengaud, M. H., Cramer, P., Neveux, E., LʼHéritier, C., Parienté, R., & Aubier, M. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06050625 · Cited by 67
Breathlessness, Alcohol, and Opiates
Bar‐Or, D., Marx, J., & Good, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206033062214 · Cited by 67
Light, R. W., Stansbury, D. W., & Webster, J. S. (1996) · CHEST Journal · doi:10.1378/chest.109.4.975 · Cited by 61
Vozoris, N. T., Wang, X., Fischer, H. D., Gershon, A. S., Bell, C. M., Gill, S. S., O’Donnell, D. E., Austin, P. C., Stephenson, A. L., & Rochon, P. A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12762 · Cited by 58
Bozkurt, B., & Mann, D. L. (2003) · Circulation · doi:10.1161/01.cir.0000075956.36340.78 · Cited by 58
Nebulized Medications for the Treatment of Dyspnea: A Literature Review
Boyden, J. Y., Connor, S. R., Otolorin, L., Nathan, S. D., Fine, P. G., Davis, M. S., & Muir, J. C. (2014) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2014.1136 · Cited by 56
Dyspnoea: assessment and pharmacological manipulation
Stark, R. (1988) · European Respiratory Journal · doi:10.1183/09031936.93.01030280 · Cited by 56
Benzodiazepine Use among Older Adults with Chronic Obstructive Pulmonary Disease
Vozoris, N. T., Fischer, H. D., Wang, X., Anderson, G., Bell, C. M., Gershon, A. S., Stephenson, A. L., Gill, S. S., & Rochon, P. A. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0056-1 · Cited by 55
Cardiac Failure and Benzodiazepines
Guilleminault, C., Clerk, A. A., Labanowski, M., Simmons, J., & Stoohs, R. A. (1993) · SLEEP · doi:10.1093/sleep/16.6.524 · Cited by 54
Chlorpromazine‐a specific effect on breathlessness?
O'Neill, P. A., Morton, P., & Stark, R. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02716.x · Cited by 45
Dowson, C., Kuijer, R. G., & Mulder, R. (2004) · Chronic Respiratory Disease · doi:10.1191/1479972304cd032rs · Cited by 43
Lareau, S. C., Meek, P., Press, D., Anholm, J. D., & Roos, P. J. (1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70044-0 · Cited by 41
Beaupré, A., Soucy, R., Phillips, R., & Bourgouin, J. (2009) · Respiration · doi:10.1159/000195530 · Cited by 36
Timms, R. M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380100049011 · Cited by 31
Allcroft, P., Margitanovic, V., Greene, A., Agar, M. R., Clark, K., Abernethy, A. P., & Currow, D. C. (2013) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0505 · Cited by 30
Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD
Stege, G., Heijdra, Y. F., van den Elshout, F. J. J., van de Ven, M. J. T., de Bruijn, P. J., van Sorge, A. A., Dekhuijzen, P. N. R., & Vos, P. J. E. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.022 · Cited by 29
Management of Moderate-to-Severe Dyspnea in Hospitalized Patients Receiving Palliative Care
Gomutbutra, P., O’Riordan, D. L., & Pantilat, S. Z. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.05.004 · Cited by 29
Dyspnoea in Advanced Disease: A Guide to Clinical Management.
Kallet, R. H. (2006) · Respiratory Care · doi:10.4187/respcare.06511264 · Cited by 26
Differing effects of the anxiolytic agents buspirone and diazepam on control of breathing
Rapoport, D. M., Greenberg, H. E., & Goldring, R. M. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.46 · Cited by 24
Williams, C. M. (2006) · The Cancer Journal · doi:10.1097/00130404-200609000-00006 · Cited by 24
Hardy, J. R., Randall, C., Pinkerton, E., Flatley, C. J., GIBBONS, K. S., & Allan, S. G. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3125-2 · Cited by 22
Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease
Runo, J. R., & Ely, E. W. (2001) · Western Journal of Medicine · doi:10.1136/ewjm.175.3.197 · Cited by 15
Dyspnoea in advanced disease : a guide to clinical management
Booth, S., & Dudgeon, D. J. (2006) · Cited by 14
Self-citationDyspnea in advanced chronic obstructive pulmonary disease.
O'Donnell, D. E. (1998) · PubMed · Cited by 14
Pharmacological management of breathlessness in advanced disease
Abernethy, A. P., Uronis, H. E., Wheeler, J. L., & Currow, D. C. (2008) · Progress in Palliative Care · doi:10.1179/096992608x291243 · Cited by 12
The genesis of breathlessness What do we understand?
Beach, D., & Schwartzstein, R. M. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198530039.003.0001 · Cited by 12
Should we exercise caution with benzodiazepine use in patients with COPD?
Rodriguez‐Roisin, R., & García‐Aymerich, J. (2014) · European Respiratory Journal · doi:10.1183/09031936.00071014 · Cited by 7
Cerchietti, L. C. A., Cabalar, M. E., & Navigante, A. H. (2003) · Medicina Paliativa · Cited by 6
Symptom management in the older adult- 2015 Update
Smith, T. J. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.01.006 · Cited by 6
Symptomkontrolle und ethische Aspekte im terminalen Verlauf einer COPD
Hörfarter, B. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-006-0289-2 · Cited by 6
Manning, H. L. (2000) · Respiratory Care · doi:10.1177/002013240004501105 · Cited by 6
Cited by
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2042st · Cited by 1,844
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Higginson, I. J., Bausewein, C., Reilly, C. C., Gao, W., Gysels, M., Dzingina, M., McCrone, P., Booth, S., Jolley, C. J., & Moxham, J. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70226-7 · Cited by 605
Self-citationHenson, L. A., Maddocks, M., Evans, C., Davidson, M., Hicks, S., & Higginson, I. J. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00470 · Cited by 367
Self-citation
Metadata
- Authors
- Simon, S. T., Higginson, I. J., Booth, S., Harding, R., Weingärtner, V., & Bausewein, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-10-20
- Volume
- 2016
- Issue
- 10
- Pages
- CD007354-CD007354
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2139343266
- Cited by
- 358
- References
- 96
- FWCI
- 33.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.